TORRENT PHARMACEUTICALS
Back to Cashflow Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,023 Cr | ₹2,585 Cr | ₹3,266 Cr | ₹2,368 Cr | ₹1,803 Cr |
What is the latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3,023 Cr |
| Mar2025 | ₹2,585 Cr |
| Mar2024 | ₹3,266 Cr |
| Mar2023 | ₹2,368 Cr |
| Mar2022 | ₹1,803 Cr |
How is Cash Flow from Operating Activities of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,023 Cr | 16.93 | |
| Mar2025 | ₹2,585 Cr | -20.85 | |
| Mar2024 | ₹3,266 Cr | 37.92 | |
| Mar2023 | ₹2,368 Cr | 31.34 | |
| Mar2022 | ₹1,803 Cr | - | |
Compare Cash Flow from Operating Activities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹176,427.6 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
| MANKIND PHARMA | ₹109,040.0 Cr | -0.9% | 15.3% | 16.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1% |
2% |
20.8% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses